Clinical trials recruiting in Hanzhong, China

Phase breakdown

Conditions recruiting in Hanzhong, China

Recruiting trials in Hanzhong, China

• Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）
  NCT07546097 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female)
• Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
  NCT04930432 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
  NCT06534658 · Phase: Not specified · Ages: 50 Years to 85 Years · Sex: All (male and female)
• TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
  NCT07047365 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）
  NCT07550673 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Hanzhong, China?

5 recruiting trials have at least one study site in Hanzhong, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.